Urine is the result of a fascinating and complex system, of which the kidneys are the star, that evolved to keep our internal ...

A groundbreaking study shows how Zepbound, a popular weight loss medication, could become a key treatment for heart failure ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...

A new study suggests that the benefits of prescribing anticoagulation drugs to certain older people outweigh the potential risks.

New dyslipidemia guidance from the American Association of Clinical Endocrinology focuses on newer medications and ...

For days, she dealt with the nagging pain. One day, she and her daughter went to the mall, and Caprario decided to run up and down the stairs to try and relieve the discomfort. On other days, she ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

News 8 spoke with the dean of the Penn State College of Medicine about what advances are being made in the treatment of ...

Dr. Kevin R. Campbell, MD, FACC, cardiologist at Health First, passionately advocates for women's heart health, raising awareness.

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Updated guidance on preventing atherosclerotic cardiovascular disease in people with dyslipidemia includes changes reflecting ...